Phase I clinical trial of TO-206 - Safety trial in patients with Japanese cedar pollinosis
Phase 1
- Conditions
- Japanese cedar pollinosis
- Registration Number
- JPRN-jRCT2080222215
- Lead Sponsor
- TORII PHARMACEUTICAL CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 70
Inclusion Criteria
1)Patients with specific IgE against cedar pollen CAP class 3 or more
2)Positive skin prick test against cedar pollen
3)Patients who have a clinical history of cedar pollinosis in 2012 and 2013 cedar pollen seasons
Exclusion Criteria
1)Patients with perennial allergic rhinitis, medication-derived rhinitis, vasomotor rhinitis or non-allergic rhinitis during therapy
2)Patients who have developed asthmatic attack within 5 years before the pre-treatment observation visit
3)Patients who have received specific immunotherapy for cedar pollinosis in history
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method